Geode Capital Management LLC Has $92.06 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Geode Capital Management LLC raised its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 11.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,339,640 shares of the company's stock after buying an additional 455,205 shares during the quarter. Geode Capital Management LLC owned 1.79% of Oscar Health worth $92,062,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC raised its position in shares of Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after buying an additional 844 shares in the last quarter. Summit Trail Advisors LLC increased its stake in Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company's stock worth $329,000 after acquiring an additional 1,065 shares during the period. KBC Group NV raised its holdings in Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after acquiring an additional 1,328 shares in the last quarter. Arizona State Retirement System lifted its position in shares of Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock valued at $602,000 after acquiring an additional 1,351 shares during the period. Finally, Amalgamated Bank grew its holdings in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Insiders Place Their Bets

In related news, COO Steven Wolin sold 19,580 shares of the business's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $354,006.40. Following the sale, the chief operating officer now owns 102,598 shares of the company's stock, valued at $1,854,971.84. The trade was a 16.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Vice Chairman Joshua Kushner bought 276,040 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now owns 5,031,262 shares in the company, valued at $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company's stock.

Analysts Set New Price Targets

OSCR has been the subject of a number of analyst reports. Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price for the company. Piper Sandler reiterated an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Jefferies Financial Group initiated coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $21.56.

Oscar Health Price Performance

OSCR stock traded up $0.59 during trading on Friday, reaching $14.09. 7,934,389 shares of the company were exchanged, compared to its average volume of 3,496,964. The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of -234.79 and a beta of 1.63. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a 50-day moving average of $15.89 and a two-hundred day moving average of $17.42. Oscar Health, Inc. has a twelve month low of $8.14 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the previous year, the firm posted ($0.29) EPS. The business's quarterly revenue was up 68.3% compared to the same quarter last year. As a group, equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.